161 related articles for article (PubMed ID: 34210485)
1. Prostate Cancer Predisposition.
Bhanji Y; Isaacs WB; Xu J; Cooney KA
Urol Clin North Am; 2021 Aug; 48(3):283-296. PubMed ID: 34210485
[TBL] [Abstract][Full Text] [Related]
2. Hereditary prostate cancer - Primetime for genetic testing?
Heidegger I; Tsaur I; Borgmann H; Surcel C; Kretschmer A; Mathieu R; Visschere P; Valerio M; van den Bergh RCN; Ost P; Tilki D; Gandaglia G; Ploussard G;
Cancer Treat Rev; 2019 Dec; 81():101927. PubMed ID: 31783313
[TBL] [Abstract][Full Text] [Related]
3. Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications.
Brandão A; Paulo P; Teixeira MR
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708810
[TBL] [Abstract][Full Text] [Related]
4. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.
Giri VN; Knudsen KE; Kelly WK; Abida W; Andriole GL; Bangma CH; Bekelman JE; Benson MC; Blanco A; Burnett A; Catalona WJ; Cooney KA; Cooperberg M; Crawford DE; Den RB; Dicker AP; Eggener S; Fleshner N; Freedman ML; Hamdy FC; Hoffman-Censits J; Hurwitz MD; Hyatt C; Isaacs WB; Kane CJ; Kantoff P; Karnes RJ; Karsh LI; Klein EA; Lin DW; Loughlin KR; Lu-Yao G; Malkowicz SB; Mann MJ; Mark JR; McCue PA; Miner MM; Morgan T; Moul JW; Myers RE; Nielsen SM; Obeid E; Pavlovich CP; Peiper SC; Penson DF; Petrylak D; Pettaway CA; Pilarski R; Pinto PA; Poage W; Raj GV; Rebbeck TR; Robson ME; Rosenberg MT; Sandler H; Sartor O; Schaeffer E; Schwartz GF; Shahin MS; Shore ND; Shuch B; Soule HR; Tomlins SA; Trabulsi EJ; Uzzo R; Vander Griend DJ; Walsh PC; Weil CJ; Wender R; Gomella LG
J Clin Oncol; 2018 Feb; 36(4):414-424. PubMed ID: 29236593
[TBL] [Abstract][Full Text] [Related]
5. Germline Predisposition to Prostate Cancer in Diverse Populations.
Bree KK; Hensley PJ; Pettaway CA
Urol Clin North Am; 2021 Aug; 48(3):411-423. PubMed ID: 34210495
[TBL] [Abstract][Full Text] [Related]
6. Germline Testing for Prostate Cancer Prognosis: Implications for Active Surveillance.
Helfand BT; Xu J
Urol Clin North Am; 2021 Aug; 48(3):401-409. PubMed ID: 34210494
[TBL] [Abstract][Full Text] [Related]
7. Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.
Liss MA; Xu J; Chen H; Kader AK
Prostate; 2015 Sep; 75(12):1322-8. PubMed ID: 25982801
[TBL] [Abstract][Full Text] [Related]
8. Germline Genetics of Prostate Cancer: Time to Incorporate Genetics into Early Detection Tools.
Fantus RJ; Helfand BT
Clin Chem; 2019 Jan; 65(1):74-79. PubMed ID: 30459162
[TBL] [Abstract][Full Text] [Related]
9. Genetically Informed Prostate Cancer Screening.
Arcot R; Morgan TM; Polascik TJ
Urol Clin North Am; 2021 Aug; 48(3):373-386. PubMed ID: 34210492
[TBL] [Abstract][Full Text] [Related]
10. Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.
Takahashi H; Lu W; Watanabe M; Katoh T; Furusato M; Tsukino H; Nakao H; Sudo A; Suzuki H; Akakura K; Ikemoto I; Asano K; Ito T; Wakui S; Muto T; Hano H
Int J Cancer; 2003 Nov; 107(2):224-8. PubMed ID: 12949798
[TBL] [Abstract][Full Text] [Related]
11. Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer.
Loeb S; Giri VN
Eur Urol Oncol; 2021 Feb; 4(1):1-9. PubMed ID: 33390340
[TBL] [Abstract][Full Text] [Related]
12. Genetic testing for hereditary prostate cancer: Current status and limitations.
Zhen JT; Syed J; Nguyen KA; Leapman MS; Agarwal N; Brierley K; Llor X; Hofstatter E; Shuch B
Cancer; 2018 Aug; 124(15):3105-3117. PubMed ID: 29669169
[TBL] [Abstract][Full Text] [Related]
13. The role of genetic testing in prostate cancer screening, diagnosis, and treatment.
de la Calle CM; Bhanji Y; Pavlovich CP; Isaacs WB
Curr Opin Oncol; 2022 May; 34(3):212-218. PubMed ID: 35238838
[TBL] [Abstract][Full Text] [Related]
14. Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population.
Han JH; Lee YS; Kim HJ; Lee SY; Myung SC
Asian J Androl; 2015; 17(2):285-91. PubMed ID: 25337833
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer risk-associated genetic markers and their potential clinical utility.
Xu J; Sun J; Zheng SL
Asian J Androl; 2013 May; 15(3):314-22. PubMed ID: 23564047
[TBL] [Abstract][Full Text] [Related]
16. KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness.
Lin HY; Huang PY; Cheng CH; Tung HY; Fang Z; Berglund AE; Chen A; French-Kwawu J; Harris D; Pow-Sang J; Yamoah K; Cleveland JL; Awasthi S; Rounbehler RJ; Gerke T; Dhillon J; Eeles R; Kote-Jarai Z; Muir K; ; Schleutker J; Pashayan N; ; Neal DE; Nielsen SF; Nordestgaard BG; Gronberg H; Wiklund F; Giles GG; Haiman CA; Travis RC; Stanford JL; Kibel AS; Cybulski C; Khaw KT; Maier C; Thibodeau SN; Teixeira MR; Cannon-Albright L; Brenner H; Kaneva R; Pandha H; ; Srinivasan S; Clements J; Batra J; Park JY
Sci Rep; 2021 Apr; 11(1):9264. PubMed ID: 33927218
[TBL] [Abstract][Full Text] [Related]
17. Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT.
Ahmed M; Goh C; Saunders E; Cieza-Borrella C; ; Kote-Jarai Z; Schumacher FR; Eeles R
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):333-342. PubMed ID: 31776447
[TBL] [Abstract][Full Text] [Related]
18. Inherited predisposition to prostate cancer.
Verhage BA; Kiemeney LA
Eur J Epidemiol; 2003; 18(11):1027-36. PubMed ID: 14620936
[TBL] [Abstract][Full Text] [Related]
19. Germline genetics in localized prostate cancer.
Ryan ST; Nguyen V; Bree KK; Holst DD; Kader AK
Curr Opin Urol; 2019 Jul; 29(4):326-333. PubMed ID: 31116139
[TBL] [Abstract][Full Text] [Related]
20. Genetic factors influencing prostate cancer risk in Norwegian men.
Chen H; Ewing CM; Zheng S; Grindedaal EM; Cooney KA; Wiley K; Djurovic S; Andreassen OA; Axcrona K; Mills IG; Xu J; Maehle L; Fosså SD; Isaacs WB
Prostate; 2018 Feb; 78(3):186-192. PubMed ID: 29181843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
